Siemens and Anglo American Platinum collaborate on digital and automation skills development in Africa

Currently, one of the most debated topics influencing innovation is digitalization and its impact on the future of employment. It is met with equal parts excitement and trepidation. No matter how you look at it, digital transformation and a truly connected global economy is already upon us.

Siemens (www.Siemens.com) has provided automation equipment and industrial networks to assist Anglo’s Engineering Skills Training Centre (ESTC). One of the pillars of Digitalization is industrial networks and security and it is crucial that these engineers understand the role of this technology in the future of mining.

As a leader in automation we are continuously expanding our leadership role in Industrial Digitalization. There is an opportunity, especially in Africa to embrace new and exponential technologies combined with human talent to accelerate industrialization and drive economic growth. “We are proud to be supporting Anglo American Platinum to advance skills and opportunities in Africa,” explains Sabine Dall’Omo, CEO for Siemens Southern and Eastern Africa.

Gary Humphries, Anglo American Platinum’s Executive Head for Processing was appreciative of Siemens completion of yet another skills project at the ESTC. In his address, Gary said, “Siemens and Anglo American Platinum have been in partnership since 2010 and we have seen approximately 298 artisans successfully trained and qualified at this centre. This vital contribution by Siemens to ESTC will significantly contribute towards the development of the human resource capabilities of our artisans and will help broaden the thinking of the students to explore new career capabilities. We celebrate the handover of the Siemens Simatic Wall and look forward to the role it will play in training the current and next generation of skilled artisans.”

We are ramping up our commitment to the region to meet our customer’s needs, expanding our portfolio for digital enterprises, supporting our customers in the manufacturing and process industries with digitalization, customization and efficiency improvements and investing in equipping our future generation with the right skills,” ends Sabine.

Distributed by APO Group on behalf of Siemens AG.

For further information on Siemens, please visit
www.Siemens.com/za/en/home.html

Contact for journalists
Keshin Govender
Head of Corporate Communications
Siemens, Southern and Eastern Africa
Phone: +2771 492 3789; email: Keshin.Govender@Siemens.com
Follow us on Twitter at: www.Twitter.com/SiemensAfrica

About Siemens
Siemens AG (www.Siemens.com) (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. With its publicly listed subsidiary Siemens Healthineers AG, the company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 377,000 employees worldwide. Further information is available on the Internet at www.Siemens.com.

Source:: Siemens and Anglo American Platinum collaborate on digital and automation skills development in Africa

      

Categories: AFRICA | Tags: | Leave a comment

South Africa: Statement By President Cyril Ramaphosa On Launch Of New Investment Drive

In the State of the Nation Address in February, I announced that a central priority for government this year is to encourage significant new investment in our economy.

This is a necessary condition for the growth of our economy and the creation of jobs on a scale that will significantly reduce current levels of unemployment.

New investment in productive sectors of the economy is therefore vital to our efforts to reduce poverty and inequality.

Investment in our economy has declined in recent years.

While total fixed investment in our economy stood at 24% of GDP in 2008, it has declined to around 19% last year.

The National Development Plan says we need to increase this to at least 30% of GDP by 2030.

Foreign direct investment declined from around R76 billion in 2008 to just R17.6 billion last year.

This has been driven by low business confidence and regulatory uncertainty; and has resulted in slow growth, along with poor growth in employment.

Economic conditions in the country are changing, however, and we are determined to work with all social partners to seize the opportunities that are opening up for greater investment and faster growth.

In line with our commitment in the State of the Nation Address, we are therefore launching an ambitious new investment drive.

This drive will culminate in an Investment Conference to be held in August or September 2018.

The Investment Conference, which will involve domestic and international investors in equal measure, is not intended merely as a forum to discuss the investment climate.

Rather, we expect the Conference to report on actual investment deals that have been concluded and to provide a platform for would-be investors to seek out opportunities in the South African market.

We are determined that the Conference produce results that can be quantified and quickly realised.

We are aiming through the Investment Conference to generate at least US$ 100 billion in new investments over the next five years.

Given the current rates of investment, this is an ambitious but realisable target that will provide a significant boost to our economy.

In preparation for the Investment Conference, I have decided to appoint four Special Envoys on Investment, who will spend the next few months engaging both domestic and foreign investors on the opportunities that exist in this country.

These are people with valuable experience in the world of business and finance and extensive networks across major markets.

I am therefore pleased and grateful that the following South Africans have accepted our invitation to be the President’s Special Envoys on Investment:

  • Mr Trevor Manuel, former Minister of Finance,
  • Mr Mcebisi Jonas, former Deputy Minister of Finance,
  • Ms Phumzile Langeni, Executive Chairperson of Afropulse Group and a non-executive director of several leading South African companies,
  • Mr Jacko Maree, Chairman of Liberty Group and former CEO of Standard Bank.

They will be travelling to major financial centres in Asia, Middle East, Europe and the Americas to meet with potential investors.

A major part of their responsibility will be to seek out investors in other parts of Africa, from Nairobi to Lagos and from Dakar to Cairo.

This is part of a broader push by government to advance economic integration in the Southern African region and across the continent.

In addition to the processes we must undertake within the country to finalise our participation in the African Continental Free Trade Area, we will also be pursuing other initiatives to promote intra-African cooperation on investment, infrastructure development, tourism and agriculture.

I am also pleased to announce the appointment of Ms Trudi Makhaya as my economic adviser. Among her immediate responsibilities will be the coordination of the work of these Special Envoys and a series of investment roadshows in preparation for the Investment Conference.

The engagements that we expect to take place will also be part of a process towards the establishment of a Presidential Council on Investment.

This evening, I will be departing for London to participate in the Commonwealth Heads of Government Meeting.

We will use this opportunity to meet with several major global companies to brief them on recent developments in the country and on our assessment of the economic challenges, risks and opportunities.

We will be communicating a clear and consistent message – that South Africa is an investment destination with significant unrealised potential.

Some of our fundamental strengths are well known. We have a thriving democracy, an independent judiciary and strong institutions. We have an advanced and diverse economy, a sophisticated and well-regulated financial sector, and extensive transport, telecommunications and energy infrastructure.

We also have a youthful population, an improving basic education system and significantly expanded higher education enrolment. In other words, despite the challenges, we are working hard to build our skills base.

We will brief investors on the measures we are undertaking to improve the investment environment.

Further to the announcements we made in the State of the Nation Address, we are making progress in stabilising strategic state owned enterprises, improving the functioning of key institutions like SARS, finalising a new Mining Charter through consultation with all stakeholders, processing legislation for the implementation of the National Minimum Wage and the promotion of labour stability, and launching the Youth Employment Service to increase the employability of first-time job seekers.

In addition, work is underway to rationalise and streamline investment regulations and reduce the cost of establishing and running businesses.

Through the more effective use of industrial incentives, special economic zones and local procurement requirements, we aim to increase investment in manufacturing and related sectors.

We are creating more opportunities for new market entrants through our competition policy, preferential procurement measures and expanded support to small and medium-sized businesses.

After several difficult years, South Africa is emerging as an increasingly attractive destination for investment.

We are encouraged by the growth in business confidence over the last few months, the strengthened rand and improved growth estimates.

We welcome the recent assessment by Goldman Sachs that South Africa is at the top of the list of potential candidates to be the “next big emerging market story” of 2018. It notes that the growth cycle is picking up after an earlier downturn in investment growth. It says that improved confidence is likely to lead to a better outlook for growth and investment.

This is confirmed by the South African Economic Update released this month by the World Bank. While the economy’s performance is improving, it notes that higher growth will require ambitious structural policies. It estimates that a successful conclusion of the Mining Charter deliberations, for example, could increase investment in the sector by 25 percent.

It is for these reasons that we are embarking on an ambitious investment drive alongside the implementation of necessary economic reforms.

South Africa has entered a new era of hope and confidence.

The task we have now is to ensure that this becomes an era of investment, growth, job creation and meaningful economic transformation.

I thank you.

Distributed by APO Group on behalf of Republic of South Africa: The Presidency.

Media files

Download logo

Source:: South Africa: Statement By President Cyril Ramaphosa On Launch Of New Investment Drive

      

Categories: AFRICA | Tags: | Leave a comment

Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials

  • Company to invest more than USD 100 million to advance research and development of new antimalarials over the next five years
  • Commitment includes expanding access to pediatric antimalarials and implementing capacity-building programs to contribute to the WHO’s target of reducing malaria-related child mortality by at least 90% by 2030
  • New opinion research in Africa shows 2030 malaria elimination targets are at risk; leaders urge investment in innovative malaria prevention and treatment tools

Novartis (www.Novartis.com) announces a five-year commitment to the fight against malaria in conjunction with the 7th Multilateral Initiative on Malaria Conference and the Malaria Summit of the Commonwealth Heads of Government meeting. Further, the company releases new African research on progress and remaining challenges toward the 2030 malaria elimination targets, together with Elimination 8 and the KEMRI-Wellcome Trust program.

Over the next five years, as part of its commitment, Novartis will invest more than USD 100 million to advance research and development of next-generation treatments to combat emerging resistance to artemisinin and other currently used antimalarials. The company will also implement an equitable pricing strategy to maximize patient access in malaria-endemic countries when these new treatments become available. In order to contribute to the WHO’s target of reducing malaria-related child mortality by at least 90% by 2030, Novartis will further help expand access to pediatric antimalarials and implement healthcare system strengthening programs in 4 sub-Saharan countries.

“Resistance to treatment presents the biggest threat to the incredible progress that has been made in the fight against malaria in the past 20 years. We cannot afford to wait; this is why we are committing to advance the research and development of next-generation treatments,” said Vas Narasimhan (https://goo.gl/sh4WL3), CEO of Novartis. “At the same time, we need to work to ensure that our innovation reaches those most in need, even those in the most remote locations.”

The R&D investment is meant to advance the Novartis malaria pipeline through 2023 and to complete a comprehensive global clinical trial program for our novel antimalarial drug candidates KAF156 and KAE609 (currently in Phase IIb and Phase IIa respectively [1]). Both are from new classes of medicines that were selected for their ability to treat malaria in different ways from current therapies. The investment also includes new uses of technology to identify areas where the malaria burden is greatest. This information could then be used to support capability- and capacity-building to establish future clinical trial sites, so the medicines can be evaluated in the populations where they are most needed.

In order to enable patients in malaria-endemic countries to afford these new treatments once they become available, the company will implement an equitable pricing strategy based on socio-economic conditions of different population segments. We plan to do so in consultation with our development and funding partners and other stakeholders.

Despite the tremendous progress made in combating malaria, one child still dies from the disease every two minutes. Novartis aims to contribute to the WHO’s target of reducing malaria-related child mortality by at least 90% in 2030. In Nigeria, the Democratic Republic of Congo and at least 2 more countries in sub-Saharan Africa that bear the highest number of malaria-related child deaths, we plan to work with partners to help expand access to our pediatric artemisinin-based combination therapy (ACT) and drive integrated community case management (iCCM) initiatives. iCCM is recognized as a key strategy (https://goo.gl/MDPYh3) for increasing access to essential treatments and reducing child mortality from treatable conditions, such as malaria, pneumonia and diarrhea.

Novartis has been committed to the fight against malaria for the past two decades, launching the first fixed-dose ACT in 1999 and the first dispersible pediatric ACT developed in partnership with Medicines for Malaria Venture (MMV) in 2009. To date, working with partners, the company has delivered more than 850 million treatments, including 350 million pediatric treatments, without profit to malaria-endemic countries.

The new commitment launches at the same time as results from a new research study (Malaria Futures for Africa, MalaFA) across 14 countries in sub-Saharan Africa. In total, 68 African experts from governments, the research community and nongovernmental organizations expressed their views on progress and remaining challenges toward the 2030 global malaria elimination targets.

Global malaria deaths have fallen by more than 60% between 2000 and 2015. Yet respondents fear progress could stall unless national governments provide more funding and international organizations target their support more effectively.

Many experts also voiced concerns that mosquitoes were increasingly resistant to insecticides and that malaria parasites could become resistant to ACTs in the next 15-20 years. Some feared that resistance would spread faster because of expanding trade and travel between Africa and Asia, where the first signs of drug resistance are emerging. Others thought it was just as likely that resistance could emerge independently in Africa.

Respondents expressed widespread support for making better use of the currently available tools, while stressing that more emphasis should be placed on improving the delivery of existing and new interventions to fight malaria – an area currently underfunded.

The MalaFA study was commissioned by Novartis and co-chaired by Dr Richard Kamwi, Ambassador, Elimination 8 (E8), and Professor Bob Snow, of the KEMRI-Wellcome Trust program, Kenya and University of Oxford, United Kingdom. Research advisers include Roll Back Malaria, Malaria No More UK and the African Leaders Malaria Alliance.

According to the 2017 World Malaria Report, there were 216 million cases of malaria in 2016, up from 211 million cases in 2015. The number of malaria deaths was 445,000 in 2016 vs. 438,000 in 2015. Ninety percent of malaria cases and over 90 percent of malaria deaths occur in sub-Saharan Africa. Children under 5 are particularly at risk, and malaria takes the life of a child every two minutes.

To download a copy of the MalaFA report: https://goo.gl/uyqL3B

For more information on our work in malaria: www.Malaria.Novartis.com

[1] Both compounds are the result of a Wellcome Trust, Medicines for Malaria Venture (MMV) and Singapore Economic Development Board-supported joint research programme with the Novartis Institute for Tropical Diseases, the Genomics Institute of the Novartis Research Foundation, and the Swiss Tropical and Public Health Institute. Novartis is developing KAF156 with scientific and financial support from MMV (in collaboration with the Bill & Melinda Gates Foundation).

Distributed by APO Group on behalf of Novartis International AG.

Novartis Media Relations
Central media line: +41 61 324 2200
E-mail: Media.Relations@Novartis.com

About Novartis
Novartis (www.Novartis.com) provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2017, the Group achieved net sales of USD 49.1 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 122,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. For more information, please visit www.Novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://Twitter.com/novartis
For Novartis multimedia content, please visit www.Novartis.com/news/media-library
For questions about the site or required registration, please contact Media.Relations@Novartis.com

Disclaimer

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “commitment,” “investing,” “to research and develop,” “to invest,” “to advance,” “to contribute,” “will,” “enable,” “committing,” “meant,” “to complete,” “drug candidates,” “to identify,” “could,” “is developing,” “future,” “can,” “plan,” “aims,” “committed,” “launches,” or similar terms, or by express or implied discussions regarding the potential fulfillment of the commitments described in this release, potential marketing approvals, new indications or labeling for the investigational described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the commitments described in this release will be fulfilled, or that they will be fulfilled at any particular time. Neither can there be any guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. In particular, our expectations regarding such commitments and products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political and economic conditions; safety, quality or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG’s current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

Source:: Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials

      

Categories: AFRICA | Tags: | Leave a comment

Marriott International Unveils Unified Loyalty Programs with One Set of Benefits

Today, Marriott International (www.Marriott.com) announced it will introduce one set of unified benefits across Marriott Rewards, The Ritz-Carlton Rewards and Starwood Preferred Guest (SPG) for its members in August 2018. This will create an incredibly rich hospitality loyalty program in which members will earn more points faster than under the prior programs — on average 20% more points for every dollar spent. For the first time, members will have access to book stays and earn or redeem points among 29 participating global brands comprising 6,500 hotels in 127 countries and territories. Additionally, the Moments experiential platform is expanding, with more than 110,000 experiences in 1,000 destinations from must-see attraction tickets and tours for purchase with cash by all guests, to once-in-a-lifetime events only available to members using points, including the new bespoke Moments Live event series.

“We listened to the travel aspirations of our members and set our sights on unlocking the full potential of our loyalty programs,” said David Flueck, Senior Vice President of Global Loyalty, Marriott International. “We are excited to announce that this August, our members can enjoy one set of benefits across our extraordinary portfolio of hotels from iconic full and select service, to extended stay, to unique boutiques and luxury brands. We hope to inspire our members whatever their travel passion, whether it is resorts featuring overwater bungalows, peaceful secluded island settings, ski-in / ski-out mountain resorts, towering hotels with picture-worthy views or even former palaces converted into hotels.”

Beginning in August, members will be able to combine their separate Marriott Rewards, The Ritz-Carlton Rewards and SPG accounts into a single account spanning the entire loyalty portfolio. The Marriott Rewards, The Ritz-Carlton Rewards and Starwood Preferred Guest (SPG) names will continue to live on under the new set of unified benefits until a new program name is introduced in 2019.

Also beginning in August, travelers will have the ability to book stays across the entire portfolio for the first time on www.Marriott.com, www.SPG.com and the Marriott and SPG apps, or by contacting customer engagement centers.

“There are no more important customers than our loyalty members,” said Karin Timpone, Global Marketing Officer, Marriott International. “With good news for our members, we decided to announce the new benefits now and launch them as quickly as possible, so members could take full advantage. At the same time, we will continue to introduce more exclusive member experiences throughout the year on our Moments platforms.”

Achieve Elite Status and Earn Points Faster

In August, members will be able to earn and redeem across the entire portfolio of participating hotels and earn elevated benefits and elite status faster with new elite tiers. For example, earning Silver elite status after just ten nights and Gold elite status after just 25 nights will become standard in all three programs. With Platinum elite status earned after 50 nights and Platinum Premier elite status earned after 75 nights, these tiers will become easier to attain for Marriott Rewards and The Ritz-Carlton Rewards members and align with SPG’s current offering. In addition, all Platinum Premier members surpassing 100 nights and $20,000 of spend will enjoy the highest level of personalized service – the popular ambassador program – along with all the other benefits in that tier. Members who have achieved Lifetime status will continue to have their status recognized.

The breakfast offering for Platinum and Platinum Premier members will be expanded to 23 participating brands, including Courtyard, AC Hotels by Marriott, Protea and Moxy, as well as all resorts. For certain brands, members will receive free breakfast or an on-property food and beverage credit for breakfast or other dining options.

Under the unified benefits, a single points currency will be introduced. When SPG members combine their accounts in August, their points balance will triple. SPG, Marriott Rewards and The Ritz-Carlton Rewards members will all earn ten points for every dollar spent at all brands except for Residence Inn, TownePlace Suites and Element which will be five points per every dollar spent. With bonuses, elite members will earn even more for stays. In August, all members will begin earning points for food and beverage and qualifying incidentals on their folio, rather than just the room rate.

Simpler to Redeem Points

To make it easier for members to redeem points, all hotels throughout the loyalty portfolio will have no blackout dates for points redemptions. In addition, a Free Night Award chart with peak, standard and off-peak pricing will be adopted for all hotels. The chart, which will launch with standard pricing in August, will add off peak and peak in 2019.

More Mobile Features

Members will enjoy a significantly improved digital and mobile experience. When members book directly on www.Marriott.com, www.SPG.com or any of Marriott’s mobile apps, they will be able to choose from all 6,500 participating hotels, and also take advantage of exclusive member-only rates and free Wi-Fi. In addition, members will be able to check-in or check out, receive Room Ready Alerts chat directly with hotels using Mobile Requests and where available use their smartphones as their room key on all of Marriott’s mobile apps.

To learn more about program changes and benefits, please go here (http://Members.Marriott.com).

Increased Access to Unparalleled Experiences

Research shows today’s modern travelers value experiences over things. Marriott’s greatly expanded experiential offerings on Moments (https://Moments.Marriott.com) can be purchased with cash and do not require a hotel reservation. As an added benefit, Marriott Rewards, The Ritz-Carlton Rewards and Starwood Preferred Guest (SPG) members will earn points every time they purchase one of the new experiences. The 110,000 new Moments experiences in 1,000 destinations are in addition to the 8,000 exclusive, member experiences that only can be redeemed with points on Marriott Rewards Moments (https://Moments.MarriottRewards.com) and SPG Moments (https://auction.StarwoodHotels.com). In the future, all Moments experiences will be available to be redeemed with points.

Experiences range from destination tours and day trips like shark cage diving in Gansbaai, South Africa, to once-in-a-lifetime events. These include exclusive member concerts, VIP experiences to coveted sports events like the Super Bowl and music festivals like Coachella Valley Music and Arts Festival, as well as hands-on master classes and meet & greets with some of the world’s top athletes, musicians and chefs, including among others, actor and musician Jared Leto, chef Daniel Boulud and Lewis Hamilton, the four-time Formula One™ World Champion and Mercedes-AMG Petronas Motorsport driver.

Marriott is also announcing Moments Live, a collection of premiere musical and culinary events powered by Marriott’s partnership with Universal Music Group (UMG) and its newest partnership with LITV Entertainment Group. The series kicks off with a selection of:

  • VIP access and exclusive performances throughout Keith Urban’s recently announced

Graffiti U World Tour.

  • Access to intimate, thoughtfully crafted events with superstar chefs and well-known musicians in picturesque settings.
  • Exclusive, VIP access to music and culinary themed events in Napa Valley, such as private festivals Live In The Vineyard and Live In The Vineyard Goes Country.

In the coming months, Marriott will provide members with information about how and when in August they can begin combining their loyalty accounts.

The information above represents a summary of the upcoming changes to Marriott’s award-winning loyalty programs and is subject to the full terms and conditions of the programs that will be available to the public at the time the changes become effective.

Distributed by APO Group on behalf of Marriott International, Inc..

Media Contact:
Anjali Mehra
+971 565396555
Anjali.Mehra@Marriott.com

Bassel Barakat
+971525347568
Bassel.Barakat@FourCommunications.com

About Marriott International, Inc.
Marriott International, Inc. (NASDAQ: MAR) (www.Marriott.com) is based in Bethesda, Maryland, USA, and encompasses a portfolio of more than 6,500 properties in 30 leading hotel brands spanning 127 countries and territories. Marriott operates and franchises hotels and licenses vacation ownership resorts all around the world. The company also operates award-winning loyalty programs: Marriott Rewards®, which includes The Ritz-Carlton Rewards®, and Starwood Preferred Guest®. For more information, please visit our website at www.Marriott.com, and for the latest company news, visit www.MarriottNewscenter.com. In addition, connect with us on Facebook (https://goo.gl/dmcgA7) and @MarriottIntl on Twitter (https://goo.gl/zQcCLQ) and Instagram (https://goo.gl/43ChEH).

Source:: Marriott International Unveils Unified Loyalty Programs with One Set of Benefits

      

Categories: AFRICA | Tags: | Leave a comment